Urinary carboxyterminal telopeptide of collagen I as a potential marker of bone metastases chemotherapy monitoring in breast cancer.

@article{Houz1999UrinaryCT,
  title={Urinary carboxyterminal telopeptide of collagen I as a potential marker of bone metastases chemotherapy monitoring in breast cancer.},
  author={Pascal Houz{\'e} and B Bellik and J. M. Extra and F Bouro and Bernard Bousquet},
  journal={Clinica chimica acta; international journal of clinical chemistry},
  year={1999},
  volume={281 1-2},
  pages={77-88}
}
Breast cancers frequently have osteoclastic bone metastases that are difficult to monitor and treat. Bone scintigraphy with 99mTc-labeled biphosphonates is still the reference method for detecting and localizing bone involvement. Classical biochemical markers such as urinary calcium have poor sensitivity for detecting and monitoring metastases of breast… CONTINUE READING